Peptidergic modulation of synaptic activity in the hippocampus

被引：0
作者：
Skrebitskii V.G. [1 ]
Kondratenko R.V. [1 ]
Povarov I.S. [1 ]
Derevyagin V.I. [1 ]
机构：
[1] Scientific Center for Neurology, Russian Academy of Medical Sciences, 105064 Moscow
来源：
Neuroscience and Behavioral Physiology | 2013年 / 43卷 / 5期
基金：
俄罗斯基础研究基金会;
关键词：
anxiolytics; hippocampus; inhibitory interneurons; IPSC; Noopept; nootropes; patch clamping; Selank;
D O I：
10.1007/s11055-013-9786-0
中图分类号：
学科分类号：
摘要：
We present here results from studies of the physiological mechanisms of action of two neuropeptides widely used in clinical practice as nootropes and anxiolytics: Noopept, a peptide analog of piracetam and, Selank, a synthetic analog of the peptide tuftsin. Patch-clamp studies on hippocampal slices addressed the modulation of spontaneous inhibitory ion currents in pyramidal neurons on exposure to study neuropeptides. The main effect of both substances consisted of an increase in the frequency of spontaneous inhibitory postsynaptic currents (IPSC) in pyramidal cells of the radial layer of field CA1, evidently due to an increase in the discharge frequency of inhibitory interneurons terminating on these cells (demonstrated only for Noopept). The consequence of the increase in IPSC frequency in pyramidal neurons is strengthening of the inhibitory control of limbic structures by the hippocampus, which in turn appears to underlie the anxiolytic effects of both agents. The mechanisms of their nootropic actions will be addressed in future studies. © 2013 Springer Science+Business Media New York.
引用
收藏
页码：650 / 655
页数：5
相关论文
共 20 条
  • [1] Belozertsev F.Y., Kozlovskii I.I., Semenova T.P., Kozlovskaya M.M., Effects of the neuropeptide Selank on acquisition of an adaptive spatial visual orientation skill in rats with impaired mnestic function, Zh. Psikhofarm. Biol. Narkol., 9, pp. 2591-2597, (2009)
  • [2] Gudasheva T.A., Ostrovskaya R.U., Maksimova F.V., Et al., Possible structural-functional relationships between piracetam and vasopressin, Khim.-Farm. Zh., 3, pp. 271-275, (1988)
  • [3] Gudasheva T.A., Ostrovskaya R.U., Trofimov S.S., Et al., Peptide analogs of piracetam as ligands of presumptive nootropic receptors, Khim.-Farm. Zh., 11, pp. 1322-1328, (1985)
  • [4] Zozulya A.A., Neznamov G.G., Syunyakov T.S., Et al., Efficacy and mechanisms of action of the new peptide anxiolytic Selank in the treatment of generalized anxiety disorder and neurasthenia, Zh. Nevrol. Psikhiat. Im. Korsakova, 13, pp. 201-210, (2008)
  • [5] Chepkova A.N., Kiapai N.A., Doreuli N.V., Et al., Effects of the amide pyroglutamylasparagine on the plastic properties of synaptic transmission in the hippocampus, Byull. Eksperim. Biol. Med., 7, pp. 68-71, (2003)
  • [6] Bertoglio L.J., Joka S.R., Guimaraes F.S., Further evidence that anxiety and memory are regionally dissociated within the hippocampus, Behav. Brain Res., 175, pp. 183-188, (2006)
  • [7] Chepkova A.N., French P., De Wied D., Et al., Long-lasting enhancement of synaptic excitability of CA1/subiculum neurons of the rat ventral hippocampus by vasopressin and vasopressin(4-8), Brain Res., 701, 1-2, pp. 255-266, (1995)
  • [8] De Wied D., Neuropeptides in learning and memory processes, Behav. Brain Res., 83, 1-2, pp. 83-90, (1997)
  • [9] Deng P.Y., Porter J.E., Shin H.S., Lei S., Thyrotropin-releasing hormone increases GABA release in rat hippocampus, J. Physiol., 577, pp. 497-511, (2006)
  • [10] Giurgea C., Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology, Actual Pharmacol. (Paris), 25, pp. 115-116, (1972)
12